Filters

See more specimen types...
See more states

Other countries

Results: 1 to 20 of 67

Tests names and labsConditionsGenes and analytesMethods

CentoICU platinum

Centogene AG - the Rare Disease Company
Germany
769514
  • C Sequence analysis of the entire coding region

CentoICU platinum plus

Centogene AG - the Rare Disease Company
Germany
769514
  • C Sequence analysis of the entire coding region

Breast cancer

Centogene AG - the Rare Disease Company
Germany
61
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Fanconi anemia type D1

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Congenital Limb Malformation Sequencing Panel with CNV Detection

PreventionGenetics
United States
6569
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Fanconi Anemia via BRCA2/FANCD1 Gene Sequencing with CNV Detection

PreventionGenetics
United States
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Fanconi Anemia Sequencing Panel

Genetic Services Laboratory University of Chicago
United States
1918
  • C Sequence analysis of the entire coding region

BRCA2 Gene Sequencing

Michigan Medical Genetics Laboratories University of Michigan
United States
71
  • C Sequence analysis of the entire coding region

Fanconi Anemia Sequencing Panel

PreventionGenetics
United States
1921
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Chromosomes, DEB Assay for Fanconi Anemia

Quest Diagnostics Nichols Institute Chantilly
United States
1515
  • B Chromosome breakage studies

Chromosome DEB Assay for Fanconi anemia, Prenatal

Quest Diagnostics Nichols Institute Chantilly
United States
1515
  • B Chromosome breakage studies

Hereditary Cancer Syndrome: Deletion/Duplication Panel

EGL Genetic Diagnostics Eurofins Clinical Diagnostics
United States
11655
  • D Deletion/duplication analysis

TumorNext-Lynch+OvaNext

Ambry Genetics
United States
8127
  • D Deletion/duplication analysis
  • M Methylation analysis
  • C Sequence analysis of the entire coding region

TumorNext-HRD

Ambry Genetics
United States
2411
  • D Deletion/duplication analysis
  • M Methylation analysis
  • C Sequence analysis of the entire coding region

TumorNext-HRD+OvaNext

Ambry Genetics
United States
6525
  • D Deletion/duplication analysis
  • M Methylation analysis
  • C Sequence analysis of the entire coding region

TumorNext-Lynch+CancerNext

Ambry Genetics
United States
9537
  • D Deletion/duplication analysis
  • M Methylation analysis
  • C Sequence analysis of the entire coding region

TumorNext-HRD+CancerNext

Ambry Genetics
United States
7934
  • D Deletion/duplication analysis
  • M Methylation analysis
  • C Sequence analysis of the entire coding region

TumorNext-BRCA

Ambry Genetics
United States
112
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

PancNext

Ambry Genetics
United States
4113
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

ProstateNext

Ambry Genetics
United States
3914
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 67

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center